Medical Plus

Uherské Hradiště 68601

0 studies enrolling now · 6 studies all time

What they study most

Ankylosing Spondylitis, Obesity, Overweight, Rheumatoid Arthritis, Type 2 Diabetes

Studies at this site

• A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes — Running, not enrolling
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity — Running, not enrolling
• An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis — Completed
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes — Running, not enrolling
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis — Completed